These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27216937)

  • 1. Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis.
    Rühlemann MC; Heinsen FA; Zenouzi R; Lieb W; Franke A; Schramm C
    Gut; 2017 Apr; 66(4):753-754. PubMed ID: 27216937
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to 'Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis' by Rühlemann
    Kummen M; Hov JR
    Gut; 2017 Apr; 66(4):755-756. PubMed ID: 27340191
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis.
    Iwasawa K; Suda W; Tsunoda T; Oikawa-Kawamoto M; Umetsu S; Inui A; Fujisawa T; Morita H; Sogo T; Hattori M
    Gut; 2017 Jul; 66(7):1344-1346. PubMed ID: 27670376
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here?
    Quraishi MN; Shaheen WA
    Aliment Pharmacol Ther; 2019 Sep; 50(5):605-606. PubMed ID: 31414544
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here? Authors' reply.
    Rühlemann M; Franke A
    Aliment Pharmacol Ther; 2019 Sep; 50(5):606-607. PubMed ID: 31414547
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
    Trottier J; Białek A; Caron P; Straka RJ; Heathcote J; Milkiewicz P; Barbier O
    Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.
    Li Y; Tang R; Leung PSC; Gershwin ME; Ma X
    Autoimmun Rev; 2017 Sep; 16(9):885-896. PubMed ID: 28698093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerosing cholangitis.
    MacFaul GR; Chapman RW
    Curr Opin Gastroenterol; 2006 May; 22(3):288-93. PubMed ID: 16550044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
    Bajer L; Kverka M; Kostovcik M; Macinga P; Dvorak J; Stehlikova Z; Brezina J; Wohl P; Spicak J; Drastich P
    World J Gastroenterol; 2017 Jul; 23(25):4548-4558. PubMed ID: 28740343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proctocolectomy for ulcerative colitis after liver transplantation for primary sclerosing cholangitis.
    Bosso MC; Marchesa PE; Ricchiuti A; Giacardi A; Cocchis D; Campi M; Palisi M; Salizzoni M
    Transplant Proc; 2009 May; 41(4):1390-2. PubMed ID: 19460568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary sclerosing cholangitis in patients with drug-induced liver injury.
    Gudnason HO; Björnsson HK; Gardarsdottir M; Thorisson HM; Olafsson S; Bergmann OM; Björnsson ES
    Dig Liver Dis; 2015 Jun; 47(6):502-7. PubMed ID: 25840876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Microbiome and Primary Sclerosing Cholangitis.
    Ali AH; Carey EJ; Lindor KD
    Semin Liver Dis; 2016 Sep; 36(4):340-348. PubMed ID: 27997974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
    Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F
    Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholestatic Liver Injury: Care of Patients With Primary Biliary Cholangitis or Primary Sclerosing Cholangitis.
    Larson L; James M; Gossard A
    AACN Adv Crit Care; 2016 Oct; 27(4):441-452. PubMed ID: 27959300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The features of mucosa-associated microbiota in primary sclerosing cholangitis.
    Torres J; Bao X; Goel A; Colombel JF; Pekow J; Jabri B; Williams KM; Castillo A; Odin JA; Meckel K; Fasihuddin F; Peter I; Itzkowitz S; Hu J
    Aliment Pharmacol Ther; 2016 Apr; 43(7):790-801. PubMed ID: 26857969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota as a cornerstone in the development of primary sclerosing cholangitis: paving the path for translational diagnostic and therapeutic approaches.
    Mooser C; Ganal-Vonarburg SC
    Gut; 2019 Aug; 68(8):1353-1355. PubMed ID: 31028154
    [No Abstract]   [Full Text] [Related]  

  • 17. Utility of Noninvasive Markers of Fibrosis in Cholestatic Liver Diseases.
    Corpechot C
    Clin Liver Dis; 2016 Feb; 20(1):143-58. PubMed ID: 26593296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognizing primary biliary cirrhosis and primary sclerosing cholangitis.
    Buckley SE; DiPalma JA
    Am Fam Physician; 1996 Jan; 53(1):195-200. PubMed ID: 8546046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbial profile in primary biliary cholangitis: Towards bioindicators.
    Lemoinne S; Marteau P
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):507-508. PubMed ID: 28797907
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary sclerosing cholangitis: a clinical update.
    Williamson KD; Chapman RW
    Br Med Bull; 2015 Jun; 114(1):53-64. PubMed ID: 25981516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.